Distinct eicosanoid patterns in severe recalcitrant nasal polyposis
Authors:
Open Access
- 28 May 2023
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 13 (11) , 2043-2054
Abstract
Background: Although altered eicosanoid levels are related to disease severity in chronic rhinosinusitis with nasal polyps (CRSwNP), identifying patients prone to recurrent nasal polyps (NPs) is still difficult. We investigated levels of nasally secreted eicosanoids before and after NP surgery in patients with or without NP recurrence (NPR) and explored potential endotypes based on pre‐surgical eicosanoid levels.Methods: Levels of leukotriene (LT) E4, LTB4, prostaglandin (PG) D2, PGE2 and 15(S) hydroxyeicosatetraenoic acid (15[S]‐HETE) were measured in nasal secretions with specific immunoassays at pre‐surgery (n = 38) and 6 and 12 months post‐surgery (n = 35), with NPR identified endoscopically. Pre‐ and post‐surgical levels were compared between patients with and without NPR. Eicosanoid patterns among patients were explored with cluster analysis and evaluated with clinical parameters.Results: Patients with recurrent NPs had pronounced pre‐surgical levels of nasal 15(S)‐HETE, PGD2 and LTE4. From pre‐surgery to 12 months post‐surgery, NPR was associated with significant decreases of 15(S)‐HETE and PGD2 relative to non‐recurrence, whereas levels of LTE4 decreased at 6 months but increased again at 12 months. Clustering revealed three potential endotypes. Clusters 1 and 3 featured high and low eicosanoid levels, respectively. Cluster 2 had higher levels of LTE4 and PGD2, lower levels of PGE2 and LTB4, and more cases of recurrent NPs and previous NP surgeries.Conclusion: Elevated nasal LTE4 12 months post‐surgery in NP recurrent subjects suggests that postoperative LTE4 measurements may indicate rapid NP regrowth. A distinct nasal eicosanoid profile may be used for the identification of the most severe recalcitrant patients in need of targeted immunomodulatory therapies.Keywords
This publication has 44 references indexed in Scilit:
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkersJournal of Allergy and Clinical Immunology, 2016
- Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory diseaseJournal of Allergy and Clinical Immunology, 2016
- Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2016
- Prostaglandin E2 inhibits mast cell–dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptorJournal of Allergy and Clinical Immunology, 2015
- Leukotriene Antagonists in Nasal Polyposis: A Meta-analysis and Systematic ReviewAmerican Journal of Rhinology & Allergy, 2013
- Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine productionJournal of Allergy and Clinical Immunology, 2013
- Mast Cell Phenotype, Location, and Activation in Severe Asthma: Data from the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulationBritish Journal of Pharmacology, 2006
- Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposisJournal of Allergy and Clinical Immunology, 2005
- Effect of Inhaled Prostaglandin E2 on Allergen-induced AsthmaAmerican Review of Respiratory Disease, 1993